oral glp 1 GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Oral GLP-1 Orforglipron Is Approved

side-effects Tesamorelin Side Effects: HIV Trial Data Breakdown Injection-site reactions hit 25% in Phase 3

They get grouped together as growth hormone peptides, and patients often assume they are more or less interchangeable

(289) conducted a meta-analysis of 23 RCTs comprising 931 hemodialysis patients, demonstrating that probiotic/prebiotic/synbiotic interventions significantly reduced plasma p-cresyl sulfate (SMD = 0.38, 95% CI: 0.61 to 0.15), endotoxin (SMD = 0.58), CRP (SMD = 0.61), and IL-6 (SMD = 0.92) [Evidence quality: Moderate - significant heterogeneity in intervention protocols]

The potential of this peptide does seem compelling